Table 2.

Tumor characteristics by statin use

Tumor characteristicsStatin use (%)
OR (95% CI)
None or <1 y≥1 y
ER/PR negative340 (19)34 (12)0.64*
HER-2 positive184 (12.6)22 (9.2)0.71
Grade
    Low332 (21)73 (27)1.44
    Moderate709 (44)122 (46)
    High565 (35)72 (27)
    Total1,606267
Stage
    In situ199 (11)39 (13)
    Local1,054 (58)188 (63)1.42§
    Distant49 (3)10 (3)
    Regional522 (29)63 (21)
    Total1825300
  • * Adjusted for age.

  • HER-2 data were available for n = 1,700 patients.

  • Low versus other grades.

  • § In situ or local versus other stages.